A weekly, one-milligram injection of semaglutide, the active ingredient in Ozempic and the weight loss drug Wegovy, was found to reduce the combined risk of major kidney complications (including kidney failure), cardiovascular events, and even death from any cause by 24% in patients with type 2 diabetes and chronic kidney disease, according to a study published in May in The New England Journal of Medicine
ReadyRx Customer Support Email: [email protected] Website: www.readyrx.com Disclaimers and Legal Notices Medical Disclaimer This publication is intended for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations
Diabetologia 66(5):958959
Learning from them is key to your success
Typically, once you are able to regain full strength and function of the shoulder, you can return to your sport with the same level of intensity